MedTrace Logo

Vascular Access in Hematological Patients - PICC Versus CVC

NCT02405728 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2018-04-10

No results posted yet for this study

Summary

The use of peripherally inserted central catheters (PICCs) represents a major advance for hematological patients, enabling the effective delivery of chemotherapy and/or blood products particularly for prolonged infusions or in situation of difficult venous access. In modern medical practice their use has increased rapidly for several reasons, including ease of insertion, many uses (e.g., drug administration and venous access), perceived safety, and cost-effectiveness compared with centrally inserted central catheters (CICCs).

Conditions

  • Vascular Access Complication

Interventions

DEVICE

Centrally inserted central catheters (CICCs)

Randomization between two well established clinical routine vascular access devices

DEVICE

Peripherally inserted central catheters (PICCs)

Randomization between two well established clinical routine vascular access devices

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Principal Investigators

  • Marco Picardi, Prof · Hematology - AOU Federico II - Napoli - Italy

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02405728 on ClinicalTrials.gov